İstanbul Journal of Pharmacy

SUBMITINFORMATION
EnglishTürkçe

Original Research


DOI :10.26650/IstanbulJPharm.2019.0052   IUP :10.26650/IstanbulJPharm.2019.0052    Full Text (PDF)

Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method

Ritesh Bhole, Khandu Chadar, Yogesh B. Zambare, Chandrakant Bonde

Background: Dofetilide is the class III antiarrhythmic drug used as a potassium channel blocker approved by US FDA in 1999 for the maintenance of sinus rhythm in individuals prone to atrial flutter and atrial fabrication. Currently there is no HPTLC-MS method reported for systematic characterization of degradation products dofetilide.

Methods: As per the ICH guidelines, the HPTLC method for the determination of dofetilide both in bulk and pharmaceutical formulation has been developed and validated. The degradation products were identified and characterized by using MS/MS. The Rf value was found to be 0.52±0.3. The degradation study was performed as per ICH guidelines (Q2R1). Isolation of the degradation product by HPTLC method and categorized by MS/MS method.

Results: The linearity of the method was found suitable over the range 100-600 ng/band with r2 of 0.998. Dofetilide was subjected to stability studies, the drug was found to degrade under various stress conditions. The recovery was found in the range of 98-101%. HPTLC-MS/MS method showed a possible degradation mechanism of 7 degrading products. The degradation of the drug under various stress conditions indicates the storage conditions for the drug and drug product during its shelf life.

Conclusion: The HPTLC method developed for its linearity, range, precision studies, LOD and LOQ can be used for the routine quality control of the drug dofetilide in bulk drugs. The degradation pathway of a drug can help in the future to identify the impurities and for the impurity profiling of dofetilide.

Keywords: Stability indicating, HPTLC, HPTLC-MS/MS degradation studies, dofetilide

PDF View

References

  • Al-Dashti, R., & Sami, M. (2001). Dofetilide: A new class III antiarrhythmic agent. The Canadian Journal of Cardiology, 17(1), 63–67. google scholar
  • Aktas, M. K., Shah, A. H., & Akiyama, T. (2007). Dofetilide-induced long QT and torsades de pointes. Annals of Noninvasive Electrocardiology, 12, 197–202. google scholar
  • Bhole, R. P., Biradar, P., & Bonde, C. G. (2018). Development and validation of stability indicating HPTLC method for estimation of dasatinib and characterization of degradation products by using mass spectroscopy. Eurasian Journal of Analytical Chemistry, 13(4), 1–11. google scholar
  • Bhole, R. P., Naksarkhre, S., & Bonde, C. G. (2019). A stability indicating HPTLC method for apremilast and identification of degradation products using MS/MS. Journal of Pharmaceutical Sciences and Research, 11(5), 1861–1869. google scholar
  • Bhole, R. P., Zombade, T., Bonde, C. G., & Zambare, Y. B. (2019). Identification and characterization of degradation products by using Ms-Ms studies for developed and validated stability indicating HPTLC method for estimation of Nintedanib Esylate in pharmaceutical dosage form. Eurasian Journal of Analytical Chemistry, 14(2), 60–70. google scholar
  • Bhole, R. P., Shinde, S. S., Chitlange, S. S., & Wankhede, S. B. (2015). A high-performance thin layer chromatography (HPTLC) method for simultaneous determination of diphenhydramine hydrochloride and naproxen sodium in tablets. Analytical Chemistry Insights, 10, 47–51. google scholar
  • Bonthagarala, B., Ch, P. K. (2003). Formulation and evalution of lansoprazole delayed release. Journal of Pharma Research, 6, 108–114. google scholar
  • Bhole, R. P., & Tamboli, F. (2018). Development and validation of stability indicating HPTLC-MS method for estimation of empagliflozin in pharmaceutical dosage form. Analytical Chemistry Letters, 8(2), 244–256. google scholar
  • Clusin, W. T. (2003). Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Critical Reviews in Clinical Laboratory Sciences, 40, 337–375. google scholar
  • Chi, Z., Liu, R., & Wang, K. (2017). A sensitive and rapid LC–MS-MS method for simultaneous determination of propafenone and its active metabolite 5-Hydroxypropafenone in human plasma and its application in a pharmacokinetic study. Journal of Chromatographic Science, 55(9), 911–917. google scholar
  • Ceresole, R., Moyano, M. A., Pizzorno, M. T., & Segall, A. (2007). Validated reversed phase HPLC method for the determination of atenolol in the presence of its major degradation product. Journal of Liquid Chromatography & Related Technologies, 29(20), 3009–3019. google scholar
  • Fegade, J. D., Bhole, R. P., Patil, V. R., & Chaudhari, R.Y. (2009). Development and validation of reverse phase high performance liquid chromatographic method for simultaneous estimation of paracetamol and piroxicam in tablet. International Journal of PharmTech Research, 1(2),184–190. google scholar
  • (2005) ICH HARMONISED TRIPARTITE GUIDELINE, https://www. ich.org/fileadmin/Public. Accessed on 04/05/2019. google scholar
  • Jadhav, S. A., Nimbalkara, K. P., Mathad, V. T., & Mali, A. C. (2013). Stability indicating RP-HPLC method for the determination of dronedarone hydrochloride and its potential process-related impurities in bulk drug and pharmaceutical dosage form. American Journal of Analytical Chemistry, 4(6), 323–335. google scholar
  • Krafte, D. S., & Volberg, W. A. (1994). Voltage dependence of cardiac delayed rectifier block by methanesulfonamide class III antiarrhythmic agents. Journal of Cardiovascular Pharmacology, 23, 37–41. google scholar
  • Kaddar, N., Pilote, S., Wong, S., Caillier, B., & Patoine, D. (2013). Simultaneous determination of dofetilide and amlodipine in plasma by HPLC. Journal of Chromatography and Separation Techniques, 4(6), 192. google scholar
  • Mounsey, J. P., & DiMarco, J. P. (2007). Cardiovascular drugs. Dofetilide. Circulation, 102, 2665–2670. google scholar
  • Qile, M., Henriett, D. M., & David, S. (2019). LUF7244, an allosteric modulator/activator of Kv11.1 channels, counteracts dofetilide induced torsades de pointes arrhythmia in the chronic atrioventricular block dog model. British Journal of Pharmacology, 176, 3871–3885. google scholar
  • Rakibe, U., Tiwari, R., Mahajan, A., Rane, V., & Wakte, P. (2018). LC and LC–MS/MS studies for the identification and characterization of degradation products of acebutolol. Journal of Pharmaceutical Analysis, 8(6), 357–365. google scholar
  • Shivashankar, V., & Gandhimathi, M. (2005). RP-HPLC method development and validation for the analyisis of dronedarone hydrochloride in tablet dosage form. Journal of Pharmacreations, 2(4), 66–71. google scholar
  • Udin, E. F., Sung, S., Hunge, K. M., & Hu, S. (2019). Development and validation of a UPLC-MS/MS analytical method for dofetilide in mouse plasma and urine, and its application to pharmacokinetic study. Journal Of Pharmaceutical And Biomedical Analysis, 172, 183–188. google scholar
  • Woolf, V. A., Miler, D. G., & Gosting, L. J. (1962). Isothermal diffusion measurements on the system H2O-Glycine-KCl at 25; Tests of the onsager reciprocal relation. Journal of American Chemical Society, 84(3), 317–331. google scholar
  • Wells, R., Khairy, P., Harris, L., Anderson, C. C., & Balaji, S. (2009). Dofetilide for atrial arrhythmias in congenital heart disease: A multicenter study. Pacing and clinical electrophysiology, 32, 1313– 1318. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Bhole, R., Chadar, K., Zambare, Y.B., & Bonde, C. (2020). Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method. İstanbul Journal of Pharmacy, 50(2), 71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052


AMA

Bhole R, Chadar K, Zambare Y B, Bonde C. Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method. İstanbul Journal of Pharmacy. 2020;50(2):71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052


ABNT

Bhole, R.; Chadar, K.; Zambare, Y.B.; Bonde, C. Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method. İstanbul Journal of Pharmacy, [Publisher Location], v. 50, n. 2, p. 71-78, 2020.


Chicago: Author-Date Style

Bhole, Ritesh, and Khandu Chadar and Yogesh B. Zambare and Chandrakant Bonde. 2020. “Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method.” İstanbul Journal of Pharmacy 50, no. 2: 71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052


Chicago: Humanities Style

Bhole, Ritesh, and Khandu Chadar and Yogesh B. Zambare and Chandrakant Bonde. “Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method.” İstanbul Journal of Pharmacy 50, no. 2 (Apr. 2024): 71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052


Harvard: Australian Style

Bhole, R & Chadar, K & Zambare, YB & Bonde, C 2020, 'Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method', İstanbul Journal of Pharmacy, vol. 50, no. 2, pp. 71-78, viewed 27 Apr. 2024, https://doi.org/10.26650/IstanbulJPharm.2019.0052


Harvard: Author-Date Style

Bhole, R. and Chadar, K. and Zambare, Y.B. and Bonde, C. (2020) ‘Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method’, İstanbul Journal of Pharmacy, 50(2), pp. 71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052 (27 Apr. 2024).


MLA

Bhole, Ritesh, and Khandu Chadar and Yogesh B. Zambare and Chandrakant Bonde. “Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method.” İstanbul Journal of Pharmacy, vol. 50, no. 2, 2020, pp. 71-78. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2019.0052


Vancouver

Bhole R, Chadar K, Zambare YB, Bonde C. Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method. İstanbul Journal of Pharmacy [Internet]. 27 Apr. 2024 [cited 27 Apr. 2024];50(2):71-78. Available from: https://doi.org/10.26650/IstanbulJPharm.2019.0052 doi: 10.26650/IstanbulJPharm.2019.0052


ISNAD

Bhole, Ritesh - Chadar, Khandu - Zambare, YogeshB. - Bonde, Chandrakant. “Development and validation of HPTLC method for estimation of dofetilide in pharmaceutical dosage form and determination of its degradation profile by MS-MS method”. İstanbul Journal of Pharmacy 50/2 (Apr. 2024): 71-78. https://doi.org/10.26650/IstanbulJPharm.2019.0052



TIMELINE


Submitted18.10.2019
Accepted29.11.2019
Published Online27.08.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.